AI in Molecular Imaging
AI-powered algorithms to drive MI further.

Molecular imaging logo for artificial intelligence.

Robust AI-powered algorithms can be used to drive clinically relevant and actionable information in a way that is quantitative, accurate, reproducible, and outcome-oriented clinical decision-making. Additionally, AI-powered algorithms may increase standardization that provides efficient automation and more operator-independent actions.

Thanks to already implemented innovative and forward-thinking technologies and the now available increased computing power, we can bring practical AI implementations to both scanners and reading solutions.

AI scanner features

AI-powered algorithms are integrated seamlessly on our Biograph™ PET/CT scanners with AIDAN1, our intelligent imaging solution. Several AI-powered features are available, such as

 

AI syngo.via features

Our syngo®.via reading solution features AI-powered applications to support automated clinical analysis of PET and SPECT images such as:

Lesion Scout with Auto ID2

Within 10 seconds and with 92% accuracy automatically assess an entire patient data set, segment all uptake, identify the foci of interest, and process a selection of foci to be excluded and included from the findings creation.

 

Auto Lung 3D3

In just 45 seconds, automatically locate and contour lungs in 3D, segment right/left lung lobes, quantify ventilation/perfusion, and generate a report containing the percentage of total perfusion and volumes.

 

Siemens Healthineers AI

Artificial intelligence (AI) is transforming care delivery and expanding precision medicine. We have served as a pioneer in AI development for more than 20 years and the new deep learning technology now enables us to automate complex diagnostics and support optimal treatment.

Siemens Healthineers has been involved in the field of machine learning since the 1990s. We own more than 500 patent families related to machine learning; more than 125 patent families thereof are related to deep learning. More than 40 offerings on the market are AI-powered.

1The features herein are not available for sale in the US and other countries on Biograph Horizon. Future availability cannot be guaranteed.

2Lesion Scout with Auto ID is not available for sale in the United States and is not commercially available in all countries. Future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
The accuracy of lesion classification has not been verified by the FDA. The lesion classification presented by Auto ID is only aproposal. All findings must be evaluated and accepted by the physician before MTV/TLG is calculated.

3Auto Lung 3D is not commercially available in all countries. Future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
Performance testing is based on CT images with a slice thickness of 2 mm or less.

The features herein do not yet fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations for Biograph mCTand Biograph Vision. They are under development and not yet commercially available in the EU and not available for sale in the US or any other country.Future availability cannot be guaranteed.